Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Baxter
McKinsey
Express Scripts
Boehringer Ingelheim

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

OXYCODONE HYDROCHLORIDE AND IBUPROFEN Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Oxycodone Hydrochloride And Ibuprofen patents expire, and what generic alternatives are available?

Oxycodone Hydrochloride And Ibuprofen is a drug marketed by Actavis Elizabeth, Barr Labs Inc, and Watson Labs. and is included in three NDAs.

The generic ingredient in OXYCODONE HYDROCHLORIDE AND IBUPROFEN is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.

Summary for OXYCODONE HYDROCHLORIDE AND IBUPROFEN
Drug patent expirations by year for OXYCODONE HYDROCHLORIDE AND IBUPROFEN
Recent Clinical Trials for OXYCODONE HYDROCHLORIDE AND IBUPROFEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Northwestern UniversityPhase 4
Milton S. Hershey Medical CenterPhase 3
CMC Ambroise ParéPhase 3

See all OXYCODONE HYDROCHLORIDE AND IBUPROFEN clinical trials

Pharmacology for OXYCODONE HYDROCHLORIDE AND IBUPROFEN
Synonyms for OXYCODONE HYDROCHLORIDE AND IBUPROFEN
701907-98-4
BYQMUJKLALSITI-RKXJKUSZSA-N
Combonox
Ibuprofen mixture with Oxycodone
Ibuprofen/Oxycodone combination
Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)-, mixt. with alpha-methyl-4-(2-methylpropyl)benzeneacetic acid
Oxycodone Ibuprofen
Oxycodone/Ibuprofen combination
SCHEMBL10915022

US Patents and Regulatory Information for OXYCODONE HYDROCHLORIDE AND IBUPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078769-001 Jan 4, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Barr Labs Inc OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078316-001 Nov 29, 2007 AB RX No Yes   Start Trial   Start Trial   Start Trial
Watson Labs OXYCODONE HYDROCHLORIDE AND IBUPROFEN ibuprofen; oxycodone hydrochloride TABLET;ORAL 078394-001 Nov 26, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
AstraZeneca
McKinsey
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.